Latest Breaking News On - Novel biosignature identified - Page 1 : comparemela.com

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, presented data at the.

United statesDan forcheAndrew wadeCory dunnFrank viciniPrnewswire prelude corporation preludedxNational cancer instituteAmerican society of clinical oncologyPrelude corporationUniversity of california san franciscoClinical oncologyNovel biosignature identifiedPoor biologic subtypeUnacceptably high ratesLocal recurrenceBreast conserving surgery